Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Review

Published on 21 Oct 2025

Overcoming cancer drug resistance: insights into Apoptotic pathway modulation by plant-based nanoparticle and natural products

in Pharmacology of Anti-Cancer Drugs

Amit Kumar Singh
Prem Prakash Kushwaha
Ajaya Kumar Singh
Abhay K. Pandey

Frontiers in Oncology

doi 10.3389/fonc.2025.1677380

592 views

Original Research

Accepted on 20 Oct 2025

Experimental Study on the Treatment of Norepinephrine Transporter-Overexpressing Pheochromocytomas and paragangliomas: A Synthetic Lethality Strategy Combining 131I-MIBG with PARP Inhibitors

in Pharmacology of Anti-Cancer Drugs

JiePing Song
Lulu zhang
Fan Qiu
Xiumin Shi
Rui Tian
Chuan Zhang
Xiaoyuan Li
Feng Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1681054

Original Research

Accepted on 17 Oct 2025

Artificial Intelligence Based Evaluation of Prognostic Benefits from Immunotherapy Plus Targeted Therapy With or Without Radiotherapy or TACE in Advanced Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Yuehong Deng
Shiqin Song
Huarong Zhao
Yuqian Yang
Simin Lu
Dieting Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1694565

260 views

Review

Accepted on 16 Oct 2025

Consensus on Managing Delayed Methotrexate Elimination in High-Dose Therapy: Insights from the Middle East

in Pharmacology of Anti-Cancer Drugs

Mubarak Al Manasour
Ahmed Absi
Ahmad Alhuraiji
Muhammad Faisal Khanani
Kayane Mheidly
Mohamed Elsaid
Mohamed Waleed Ballora
Murtadha Al-Khabori
Naser Al Zain
Nisreen Khalifa

Frontiers in Oncology

doi 10.3389/fonc.2025.1660937

114 views

Original Research

Accepted on 15 Oct 2025

Mechanism of Active Component β-Sitosterol from Myristica fragrans Inducing Apoptosis in Bladder Cancer Cells via Regulating the BCL-2/BAX/Caspase-3 Pathway

in Pharmacology of Anti-Cancer Drugs

Yongkang Zhu
Zhao Tang
Zhaoyue Lu
Dongyang Gao
Hao Pan
Haozhe Jiang
Zhen Zhang
Huiqing Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1698721

153 views

Systematic Review

Published on 15 Oct 2025

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Yanlin Wang
Wen Sun
Bing Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1667282

403 views

Review

Published on 13 Oct 2025

The role of cytostatic in oxidative stress reactions

in Pharmacology of Anti-Cancer Drugs

Renata Polaniak
Aleksander Kwiatkowski
Michał Górski
Elżbieta Grochowska-Niedworok
Małgorzata Latocha

Frontiers in Oncology

doi 10.3389/fonc.2025.1667522

559 views

Case Report

Published on 13 Oct 2025

A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer

in Pharmacology of Anti-Cancer Drugs

Caroline Anthon
Hugo Pierret
Frederic Houssiau
Astrid De Cuyper
Cédric Van Marcke
Marc Van Den Eynde
Filomena Mazzeo
Frank Cornelis
Rachel Galot
Francois P. Duhoux

Frontiers in Oncology

doi 10.3389/fonc.2025.1658621

318 views

Editorial

Published on 10 Oct 2025

Editorial: Drug development for pancreatic cancer: novel targets, drug candidates and mechanisms

in Pharmacology of Anti-Cancer Drugs

Xiao Sun
HongDe Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1705678

674 views

Original Research

Published on 08 Oct 2025

Lathyrol inhibits the proliferation of Renca cells by altering expression of TGF-β/Smad pathway components and subsequently affecting the cell cycle

in Pharmacology of Anti-Cancer Drugs

Shengyou Song
Yalin Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1629962

647 views

Case Report

Published on 06 Oct 2025

Case Report: Bevacizumab-induced renal-limited TMA and FSGS-like lesions in a kidney transplant recipient

in Pharmacology of Anti-Cancer Drugs

Xingxing Jian
Ge Liu
Shuangyan Yu
Jie Sheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1638274

637 views

Correction

Published on 01 Oct 2025

Correction: Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

in Pharmacology of Anti-Cancer Drugs

Wei Li
Yalan Zhong
Yuqiao Song
Hongmei Wang
Zheng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1705973

978 views

Correction

Published on 29 Sep 2025

Correction: Integrating network pharmacology and transcriptomics to identify solasonine’s anti-osteosarcoma targets and experimental validation

in Pharmacology of Anti-Cancer Drugs

Daihao Wei
Minyu Li
Dawei Chu
Jiandang Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1682157

746 views

Original Research

Published on 26 Sep 2025

Andrographolide suppresses chondrosarcoma cell migration and invasion by inhibiting the PI3K/Akt/mTOR signaling pathway and activating autophagy

in Pharmacology of Anti-Cancer Drugs

Chun-Fei Wu
Li-xin Ouyang
Wan-hao Zhang
Shuo Yang
Xian-Xing Zhong
Yong Lin
Shuai Fan
Peng Li
Zu-Jian Liang

Frontiers in Oncology

doi 10.3389/fonc.2025.1622666

2,222 views

Data Report

Published on 25 Sep 2025

An analysis of FDA drug approvals for oncological hematological malignancies in relation to companion diagnostics

in Pharmacology of Anti-Cancer Drugs

Jan Trøst Jørgensen

Frontiers in Oncology

doi 10.3389/fonc.2025.1635491

2,367 views

Editorial

Published on 24 Sep 2025

Editorial: Head and neck squamous cell carcinoma: navigating the dawn of personalized medicine

in Pharmacology of Anti-Cancer Drugs

Luis Abel Quiñones
Ye Guo
Fujun Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1684617

1,305 views